Semler Scientific (SMLR) Competitors

Semler Scientific (NASDAQ:SMLR) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

Does the media prefer SMLR or PRCT?

In the previous week, PROCEPT BioRobotics had 15 more articles in the media than Semler Scientific. MarketBeat recorded 19 mentions for PROCEPT BioRobotics and 4 mentions for Semler Scientific. Semler Scientific's average media sentiment score of 0.64 beat PROCEPT BioRobotics' score of 0.21 indicating that Semler Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Semler Scientific	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals have more ownership in SMLR or PRCT?

49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 16.4% of Semler Scientific shares are owned by company insiders. Comparatively, 6.6% of PROCEPT BioRobotics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Do analysts rate SMLR or PRCT?

Semler Scientific currently has a consensus target price of $81.75, indicating a potential upside of 141.58%. PROCEPT BioRobotics has a consensus target price of $74.88, indicating a potential upside of 80.03%. Given Semler Scientific's stronger consensus rating and higher probable upside, equities research analysts plainly believe Semler Scientific is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semler Scientific	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
PROCEPT BioRobotics	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Which has more risk and volatility, SMLR or PRCT?

Semler Scientific has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.

Which has stronger earnings and valuation, SMLR or PRCT?

Semler Scientific has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semler Scientific	$56.29M	8.90	$40.90M	$2.43	13.93
PROCEPT BioRobotics	$224.50M	10.31	-$91.41M	-$1.55	-26.83

Is SMLR or PRCT more profitable?

Semler Scientific has a net margin of 86.20% compared to PROCEPT BioRobotics' net margin of -30.60%. Semler Scientific's return on equity of 43.84% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Semler Scientific	86.20%	43.84%	32.88%
PROCEPT BioRobotics	-30.60%	-23.73%	-17.34%

Summary

Semler Scientific beats PROCEPT BioRobotics on 12 of the 17 factors compared between the two stocks.